The 9th Annual Symposium on Contemporary Management of Cardiovascular Disease in Women reviews prevention, diagnosis, and treatment through a sex-specific clinical lens. Held September 26, 2026, at the Millennium Biltmore Hotel in Los Angeles with an online participation option, the program was directed by Christina Economides, MD, MM, FSCAI, with support from PIH Health Good Samaritan Hospital. Sessions cover obesity and heart failure, pulmonary hypertension, lipids, atrial fibrillation, pulmonary embolism, valve disease, and cardiomyopathies. Coronary intervention vignettes connect these subjects to clinical decision-making. The symposium is relevant to cardiologists, primary care clinicians, and other healthcare professionals caring for women with cardiovascular disease.
Main Objective
The objective of this symposium is to educate healthcare providers on gender-specific approaches in prevention, diagnosis, and treatment of women with a broad range of cardiovascular diseases. Women’s CV DLA
Learning Objectives
By the end of the symposium participants will be able to:
- Identify sex-specific risk factors and clinical presentations associated with cardiovascular disease in women.
- Apply current evidence-based guidelines for the prevention, diagnosis, and management of cardiovascular disease in women across their lifespan.
- Develop patient-centered strategies to improve cardiovascular risk assessment, education, and outcomes for women in diverse clinical settings. Women’s CV DLA
Agenda and purchase scope: The schedule below describes the original hybrid event; it does not confirm recording coverage of every session. Breakfast and lunch product theatres are identified as non-CME sessions. Lecture titles are reproduced as program titles. Provider registration, live attendance, streaming-platform access, memberships, apps, accounts, and publisher-hosted extras are not included unless explicitly listed as store files.
+ Topics:
Saturday, September 26, 2026
7:00am Registration/Visit Exhibits
7:15-7:45 Coffee Convocation Lecture The State of Women Cardiologists: Evidence, Equity, and Excellence Christina Economides, MD, MM, FSCAI Katrine Zhiroff, MD, MBA, FACC, FSCAI
7:45-8:45 Breakfast – Product Theatre (Non-CME) The Next Beat: KERENDIA (Finerenone) for Your Patients with Heart Failure (HF) with Left Ventricular Ejection Fraction (LVEF) >40% Speaker: Payal Kohli, MD, FACC Supported by: Bayer
8:45-8:55 Visit Exhibits
8:55-9:00 Welcome and Introductory Remarks Christina Economides, MD, MM, FSCAI
9:00-9:20 Intersection of Obesity and Heart Failure: Role of GLP1 Agonists Michelle Kittleson, MD, PhD
9:20-9:40 Pulmonary Arterial Hypertension (PAH): Call to Action for Early Diagnosis and Treatment Ronald Oudiz, MD
9:40-10:00 FDA Black Box Warning Removed: Changing Perspective on Safety of HRT in Postmenopausal Women Janet Wei, MD, FACC
10:00-10:20 Earlier Intervention: 2026 Dyslipidemia Guidelines Karol Watson, MD, PhD, FACC
10:20-10:30 Question & Answer
10:30-10:40 Break/Visit Exhibits
10:40-11:00 Atrial Fibrillation Ablation: Outcomes in Women Ravi Sureddi, MD
11:00-11:20 2026 Acute PE Guidelines: Sex Differences in Prevalence, Presentation and Treatment Nichelle Megowan, MD
11:20-11:40 Lifetime Management of Aortic Stenosis Katrine Zhiroff, MD, MBA, FACC, FSCAI
11:40-12:00 Tricuspid Valve: Identifying Candidates for Advanced Device Therapies Steven Burstein, MD
12:00-12:10 Question & Answer
12:10-1:10 Lunch – Product Theatre (Non-CME) Unmasking hATTR Polyneuropathy Speaker: Dr. Vasvi Singh Supported by: AstraZeneca
1:10-1:20 Break/Visit Exhibits
1:20-1:35 Cardiovascular Disease in Women: 2026 Update Christina Economides, MD, MM, FSCAI
1:35-1:50 Treatment of Cardiovascular-Kidney-Metabolic (CKM) Syndrome Christina Economides, MD, MM, FSCAI
1:50-2:10 Clinical Approach to the Diagnosis and Treatment of Cardiac Amyloidosis Joseph Rahman, MD
2:10-2:30 Peripartum Cardiomyopathy with Improved EF: A Recovery or Remission Uri Elkayam, MD, FACC
2:30-3:00 Hypertrophic Cardiomyopathy in Women, Prevalence and Presentation New Therapeutic Approach: Invasive versus Medical Evidence and Clinical Experience Joseph Rahman, MD Katrine Zhiroff, MD, MBA, FACC, FSCAI
3:00-3:10 Question & Answer
3:10-3:20 Break/Visit Exhibits
3:20-4:10 Vignettes: Clinical Decision-Making for Coronary Artery Disease Drug-Coated Balloon Angioplasty
- Intravascular Lithotripsy for Calcified CAD in Women
- Mechanical Circulatory Support for High-Risk PCI
- Revascularization in Ischemic Cardiomyopathy
Moderators:
Christina Economides, MD, MM, FSCAI
Katrine Zhiroff, MD, MBA, FACC, FSCAI
4:10-4:25 Question & Answer
4:25-4:30 Closing Remarks
4:30 Adjourn



